⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Hazeltree 2025 Year-in-Review Finds Hedge Fund Crowding Diverged Sharply by Region
businesswire.com
GOOGL
MSFT
META
IBM
SNPS
BAC
USB
WFC
JPM
KEY
MRK
AMGN
TMO
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NVS
BIIB
VTRS
UCB
BMY
ABBV
REGN
SNY
LLY
JNJ
HOPE
GCBC
AMGN
TAK
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
globenewswire.com
JNJ
BIIB
NVS
VTRS
RPRX
ABBV
AZN
MRK
RIGL
GSK
REGN
GILD
AMGN
LLY
BMY
XBI
IBB
Biomedical and ICT Convergence Market Research Report 2025-2030: Outlook for Various Biomedical Products, Services, and Solutions Poised to Benefit from Various IT and Telecom Technologies - ResearchAndMarkets.com
businesswire.com
ABT
AMGN
ADI
AZN
BIIB
BIO
XRAY
GEHC
GILD
HON
JNJ
MD
MRK
NVDA
NOVT
NVO
NXPI
PFE
SMCI
SOXX
TE
TXN
TMO
WMT
ZBH
Inflammatory Diseases Biologics Market to Reach USD 157.31 Billion by 2033 as Targeted Immunology Therapies Redefine Long-Term Disease Control
prnewswire.com
AMGN
NVS
JNJ
PFE
GSK
ABBV
SNY
LLY
RO ANNOUNCES RESEARCH COLLABORATION TO BETTER UNDERSTAND AND IMPROVE THE REAL-WORLD PATIENT EXPERIENCE WITH GLP-1S
prnewswire.com
AMGN
BioMarin Appoints Arpit Davé Chief Digital and Information Officer
prnewswire.com
BMRN
AMGN
BMY
MRK
Atherosclerotic Cardiovascular Disease Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2025–2034) | DelveInsight
globenewswire.com
AMGN
ARWR
IONS
NVS
NVO
MRK
LLY
REGN
ESPR
ALNY
VRTX
XBI
diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy
prnewswire.com
BIIB
AMGN
LLY
JNJ
PFE
MRK
BMY
GILD
REGN
AZN
ABBV
SNY
NVO
LULU
GOOG
MSFT
AMZN
META
TSLA
NVDA
XOM
CVX
KO
PEP
MCD
DIS
BA
CAT
GS
JPM
BAC
WFC
C
T
VZ
CMCSA
NFLX
ADBE
CRM
INTC
QCOM
AMD
CSCO
HON
GE
IBM
ORCL
SAP
ACN
MU
AMAT
LRCX
ADI
TXN
NXPI
MRVL
MCHP
PYPL
CMG
SBUX
NKE
HD
PG
UNH
ELV
CVS
CI
HCA
MCK
CAH
Компания Alamar Biosciences объявляет о закрытии финансирования за счет конвертируемых облигаций с превышением лимита подписки и о расширении руководящей команды USA - Pусский Korea - 한국어 USA - English APAC - English USA - English USA - Français USA -
prnewswire.com
ILMN
VERA
OM
MYGN
RVT
CSGP
BIIB
AMGN
PFE
TROW